Policy
In a Cabinet meeting, Health Secretary Robert F. Kennedy Jr. said the website could go live “probably in the next 10 days,” but an exact launch date remains unclear.
FEATURED STORIES
An inconsistent boom-and-bust cycle funding environment for early-stage biotech innovations and burdensome regulation threaten the U.S.’s half-century-long dominance in the biotech sector.
Acadia Pharma’s Catherine Owen Adams is one of the founders of a group of small- to mid-cap biotechs advocating against a ‘peanut butter blanket’ approach to drug pricing for small companies.
Former European Trade Commissioner Phil Hogan and former U.S. Senator Richard Burr, speaking on a panel at the J.P. Morgan Healthcare Conference, pushed to see a larger picture beyond the Trump administration’s year of chaos and confusion.
Subscribe to BioPharm Executive
Market insights and trending stories for biopharma leaders, in your inbox every Wednesday
THE LATEST
Private investigators believe the prominent billionaire couple were murdered by multiple people two days before their bodies were discovered.
The medtech titan logged a series of legal wins this week.
The device failure was traced to a fault that prevents the LifeVest from charging its high-energy capacitors, according to the alert.
The agency would have to furlough about 45 percent of its staff.
The USPTO is paving the way for generic challengers to J&J’s prostate cancer drug Zytiga.
The Dec. 21 letter to San Diego-based Imprimis was posted on the FDA’s website on Tuesday.
Starkey’s longtime former president Jerry Ruzicka, CFO Scott Nelson and vice president of human resources Larry Miller were all fired in September 2015.
According to news reports, a six-year-old girl in North Texas was provided Tamiflu and had a rare reaction that affected her nervous system.
The mom of three is now the seventh Scottish woman to join a group legal action against Bayer.
The fine was over Teva paying bribes to foreign officials to win business in Russia, Ukraine and Mexico, the ministry said.